Showing results (71-80 of 104) with videos related to
Sort By:
Pageof 11
Journal of Neurochemistry|January 8, 2019
Neuroprotective potential of adenosine A1 receptor partial agonists in experimental models of cerebral ischemiaAlberto Martire, Catia Lambertucci, Rita Pepponi, et al.Journal of Medicinal Chemistry|June 19, 2026
Applying Deep-Learning-Driven De Novo Design to Hit Identification: A Case Study on A2A Adenosine Receptor AntagonistsMargherita Persico, Alessandra Micoli, Veronica Salmaso, et al.Journal of Medicinal Chemistry|July 18, 2009
Adenine-based acyclic nucleotides as novel P2X3 receptor ligandsRosaria Volpini, Ram Chandra Mishra, Dhuldeo D Kachare, et al.Cells|July 26, 2020
Adenosine Receptors as Neuroinflammation Modulators: Role of A1 Agonists and A2A AntagonistsAleix Martí Navia, Diego Dal Ben, Catia Lambertucci, et al.European Journal of Medicinal Chemistry|September 28, 2014
Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at α1 and 5-HT1A receptorsSilvia Franchini, Umberto M Battisti, Annamaria Baraldi, et al.Bioorganic & Medicinal Chemistry Letters|October 12, 2005
3-Arylpiperazinylethyl-1H-pyrrolo[2,3-d]pyrimidine-2,4(3H,7H)-dione derivatives as novel, high-affinity and selective alpha(1)-adrenoceptor ligandsValeria Pittalà, Giuseppe Romeo, Loredana Salerno, et al.Bioorganic & Medicinal Chemistry|May 6, 2008
Muscarinic antagonists with multiple stereocenters: Synthesis, affinity profile and functional activity of isomeric 1-methyl-2-(2,2-alkylaryl-1,3-oxathiolan-5-yl)pyrrolidine sulfoxide derivativesSilvia Dei, Cristina Bellucci, Michela Buccioni, et al.Pharmaceuticals (Basel, Switzerland)|August 6, 2021
Design and Synthesis of Novel Thiazolo[5,4-d]pyrimidine Derivatives with High Affinity for Both the Adenosine A1 and A2A Receptors, and Efficacy in Animal Models of DepressionFlavia Varano, Daniela Catarzi, Erica Vigiani, et al.Chemmedchem|April 4, 2009
Adenosine A2A receptor antagonists: new 8-substituted 9-ethyladenines as tools for in vivo rat models of Parkinson's diseaseRosaria Volpini, Diego Dal Ben, Catia Lambertucci, et al.Journal of Medicinal Chemistry|June 8, 2017
The 1,2,4-Triazolo[4,3-a]pyrazin-3-one as a Versatile Scaffold for the Design of Potent Adenosine Human Receptor Antagonists. Structural Investigations to Target the A2A Receptor SubtypeMatteo Falsini, Lucia Squarcialupi, Daniela Catarzi, et al.Pageof 11